Sep 16, 2020 / 05:15PM GMT
David Reed Risinger - Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
Great. So good afternoon, everyone, and thank you for joining us for the Bausch session. This is Dave Risinger. I cover both major and specialty pharmaceuticals. And it's a pleasure for me to welcome both Joe Papa, Chairman and CEO; and also Paul Herendeen, CFO.
And we're on a bit of a tight time slot here. I did want to read this disclaimer very quickly. But I'm pleased to also highlight that Bausch has posted slides on its website. That management will be referring to you as some new disclosures.
And so I just need to mention that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley site at www.morganstanley.com/researchdisclosures. And if you have any questions,
Bausch Health Companies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers